United States · FDA National Drug Code directory
Deferasirox
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-550_ce7e02d0-319e-4a5b-87e1-c6550ab4322c
- Product NDC
- 69097-550
- Form
- GRANULE
- Composition / generic term
- Deferasirox
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220223
- Source listing expiry
- 20261231
Source-listed ingredients
- DEFERASIROX — 90 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 PACKET in 1 CARTON (69097-550-53) / 1 GRANULE in 1 PACKET · 69097-550-53
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →